Infographic
Thought leadership
January 01, 2026
57% of Labs Still Review Peripheral Blood Smears Manually: The Case for Full-Field Digital Morphology
Clinical laboratories perform more than 13 billion tests in the U.S. each year, and 70% of medical decisions depend on their results. Yet the hematology morphology workflow – one of the most critical steps in that chain – remains largely manual, subjective, and constrained by geography.
Scopio surveyed over 700 laboratory professionals and clinicians to understand what’s happening inside today’s hematology labs. The findings paint a clear picture: labs are stretched to the breaking point.
What the data shows:
- Manual microscopy still dominates. 57% of lab professionals still rely on purely manual review of peripheral blood smears – an expert looking through a microscope, manually classifying and counting cells by type.
- Staffing and workload are at a tipping point. Labs report ever-increasing workloads alongside a critical shortage of qualified personnel and tightening budgets.
- Remote access is a gap, not a feature. More than half of laboratories have either limited or no on-site access to expert consultation for peripheral blood smear reviews, which can significantly delay diagnosis.
- The volume is high. 24% of labs process more than 100 peripheral blood smears per day, yet the majority still lack digital tools to manage that volume efficiently.
- Why Full-Field matters: Unlike cell-snapshot systems that digitize limited regions of the sample, Full-Field digital morphology captures all clinically relevant areas at 100x resolution – enabling up to 60% faster review times, consistent AI-powered decision support, and real-time remote access through the hospital’s secure network. Every case starts and ends on screen.
The infographic also introduces Complete Blood Morphology (CBM) – designed to autonomously analyze 90% of all slides by evaluating 10x more cells than today’s standard.